1 of 7next Page
Financial Statements

Bayer Group Consolidated Income Statements

 [Table 22]
  1st Quarter
2014
1st Quarter
2015
  € million € million
Net sales 10,555 12,117
Cost of goods sold (4,815) (5,566)
Gross profit 5,740 6,551
     
Selling expenses (2,443) (3,005)
Research and development expenses (820) (956)
General administration expenses (417) (483)
Other operating income 129 259
Other operating expenses (93) (368)
EBIT1 2,096 1,998
     
Equity-method gain (loss) (5) 6
Financial income 92 12
Financial expenses (246) (292)
Financial result (159) (274)
     
Income before income taxes 1,937 1,724
     
Income taxes (512) (415)
     
Income after income taxes 1,425 1,309
of which attributable to non-controlling interest 2 6
of which attributable to Bayer AG stockholders (net income) 1,423 1,303
     
 
Earnings per share    
Basic 1.72 1.58
Diluted 1.72 1.58
1 EBIT = earnings before financial result and taxes
1 of 7next Page
Last updated: April 30, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q1.bayer.com